Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The clinical efficacy of alprazolam has been evaluated in both anxiety states and depressive disorders. In anxiety neurosis, studies have been conducted vs placebo and/or other benzodiazepine tranquilizers. Reports, to date, with regard to panic/phobia disorders have been limited to open-label studies and a single report from a placebo-controlled study. In depression, both open-label and double-blind studies (vs tricyclic antidepressants) have been published.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on